Oxford Asset Management’s Global Cord Blood Corporation CO Stock Holding History

Oxford Asset Management’s Portfolio CO Stock Details CO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-43,489	Closed	-$251K	–	2109
2019 Q2	$251K	Sell	43,489 -76,511	-64%	-$504K	0.01%	1498
2019 Q1	$842K	Buy	120,000 +66,630	+125%	+$440K	0.02%	1015
2018 Q4	$344K	Buy	+53,370	New	+$341K	0.01%	1347
2018 Q3	–	Sell	-133,224	Closed	-$1.26M	–	2103
2018 Q2	$1.26M	Buy	133,224 +56,945	+75%	+$546K	0.02%	910
2018 Q1	$778K	Buy	+76,279	New	+$779K	0.02%	1060

Other funds holding CO

JCM

Jayhawk Capital Management Shawnee, Kansas $59.9M AUM 22.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

OMC

Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

QOP

Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Oxford Asset Management's CO Position: Q3 2019 in Review

Oxford Asset Management sold out of Global Cord Blood Corporation (CO) in Q3 2019, closing a stake of 43,489 shares — an estimated $251K sold.

Oxford Asset Management first reported a position in CO in Q1 2018 and held it in 5 quarters. The position peaked at $1.26M in Q2 2018. 44 funds tracked by Wall St. Rank hold CO as of Q3 2019.

Oxford Asset Management reported no remaining Global Cord Blood Corporation position as of Q3 2019 after selling out during the quarter.
Oxford Asset Management sold 43,489 Global Cord Blood Corporation shares in Q3 2019, an estimated $251K.
Oxford Asset Management first reported a position in Global Cord Blood Corporation in Q1 2018 and held it in 5 quarters.
Oxford Asset Management's Global Cord Blood Corporation position peaked at $1.26M in Q2 2018.
44 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q3 2019.

Based on Oxford Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.